Visceral leishmaniasis in a patient with active HBV/HDV co-infection

Tommaso Lupia; Silvia Corcione; Lucio Boglione; Giuseppe Cariti; Francesco G. De Rosa

doi:10.1016/j.jiph.2019.07.026

Visceral leishmaniasis in a patient with active HBV/HDV co-infection

Tommaso Lupia, Silvia Corcione, Lucio Boglione, Giuseppe Cariti, Francesco G. De Rosa

Research output: Contribution to journal › Article › peer-review

Abstract

Visceral leishmaniasis (VL) is an endemic infection in different regions of Italy and Europe caused by protozoan parasites of the genus Leishmania, transmitted to humans through sandflies bites. Reactivation after Solid Organ Transplantation was reported and could be a risk of organ rejection. A 48 years old woman was admitted to our hospital, complaining about low-grade fever, loss of weight and new onset pancytopenia in a known cirrhosis due to active HBV/HDV co-infection. Clinical, microbiological and anatomo-pathological elements were pivotal to define the diagnosis of VL and started an appropriate anti-infective treatment. After that she underwent liver transplantation and a therapy for VL was set. No signs of reactivation were reported in the 14 months of follow-up.

Original language	English
Pages (from-to)	306-308
Number of pages	3
Journal	Journal of Infection and Public Health
Volume	13
Issue number	2
DOIs	https://doi.org/10.1016/j.jiph.2019.07.026
Publication status	Published - Feb 2020
Externally published	Yes

Keywords

HBV
HDV
Leishmaniasis
Liposomial amphotericin B
Pancytopenia
Solid organ transplant

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jiph.2019.07.026

Cite this

@article{56061d520da94456adfdbb5393c8d685,

title = "Visceral leishmaniasis in a patient with active HBV/HDV co-infection",

abstract = "Visceral leishmaniasis (VL) is an endemic infection in different regions of Italy and Europe caused by protozoan parasites of the genus Leishmania, transmitted to humans through sandflies bites. Reactivation after Solid Organ Transplantation was reported and could be a risk of organ rejection. A 48 years old woman was admitted to our hospital, complaining about low-grade fever, loss of weight and new onset pancytopenia in a known cirrhosis due to active HBV/HDV co-infection. Clinical, microbiological and anatomo-pathological elements were pivotal to define the diagnosis of VL and started an appropriate anti-infective treatment. After that she underwent liver transplantation and a therapy for VL was set. No signs of reactivation were reported in the 14 months of follow-up.",

keywords = "HBV, HDV, Leishmaniasis, Liposomial amphotericin B, Pancytopenia, Solid organ transplant",

author = "Tommaso Lupia and Silvia Corcione and Lucio Boglione and Giuseppe Cariti and {De Rosa}, {Francesco G.}",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors",

year = "2020",

month = feb,

doi = "10.1016/j.jiph.2019.07.026",

language = "English",

volume = "13",

pages = "306--308",

journal = "Journal of Infection and Public Health",

issn = "1876-0341",

publisher = "Elsevier Ltd.",

number = "2",

}

TY - JOUR

T1 - Visceral leishmaniasis in a patient with active HBV/HDV co-infection

AU - Lupia, Tommaso

AU - Corcione, Silvia

AU - Boglione, Lucio

AU - Cariti, Giuseppe

AU - De Rosa, Francesco G.

PY - 2020/2

Y1 - 2020/2

N2 - Visceral leishmaniasis (VL) is an endemic infection in different regions of Italy and Europe caused by protozoan parasites of the genus Leishmania, transmitted to humans through sandflies bites. Reactivation after Solid Organ Transplantation was reported and could be a risk of organ rejection. A 48 years old woman was admitted to our hospital, complaining about low-grade fever, loss of weight and new onset pancytopenia in a known cirrhosis due to active HBV/HDV co-infection. Clinical, microbiological and anatomo-pathological elements were pivotal to define the diagnosis of VL and started an appropriate anti-infective treatment. After that she underwent liver transplantation and a therapy for VL was set. No signs of reactivation were reported in the 14 months of follow-up.

AB - Visceral leishmaniasis (VL) is an endemic infection in different regions of Italy and Europe caused by protozoan parasites of the genus Leishmania, transmitted to humans through sandflies bites. Reactivation after Solid Organ Transplantation was reported and could be a risk of organ rejection. A 48 years old woman was admitted to our hospital, complaining about low-grade fever, loss of weight and new onset pancytopenia in a known cirrhosis due to active HBV/HDV co-infection. Clinical, microbiological and anatomo-pathological elements were pivotal to define the diagnosis of VL and started an appropriate anti-infective treatment. After that she underwent liver transplantation and a therapy for VL was set. No signs of reactivation were reported in the 14 months of follow-up.

KW - HBV

KW - HDV

KW - Leishmaniasis

KW - Liposomial amphotericin B

KW - Pancytopenia

KW - Solid organ transplant

UR - http://www.scopus.com/inward/record.url?scp=85070360967&partnerID=8YFLogxK

U2 - 10.1016/j.jiph.2019.07.026

DO - 10.1016/j.jiph.2019.07.026

M3 - Article

SN - 1876-0341

VL - 13

SP - 306

EP - 308

JO - Journal of Infection and Public Health

JF - Journal of Infection and Public Health

IS - 2

ER -

Visceral leishmaniasis in a patient with active HBV/HDV co-infection

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this